- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07624552
Impact of Atrioventricular Delay Optimization on Ventricular Function in Conduction System Pacing (OPTI-CSP)
The Effect Of Atrioventricular Delay Optimization On Ventricular Functions In Patients Undergoing Conduction System Pacing
Conduction system pacing has emerged as a physiological pacing strategy that preserves ventricular electrical activation and minimizes pacing-induced dyssynchrony. However, the optimal atrioventricular delay setting in patients undergoing conduction system pacing remains uncertain.
This study aims to evaluate the effects of individualized echocardiography-guided atrioventricular delay optimization on ventricular function and hemodynamic performance in patients with conduction system pacing. Echocardiographic parameters including global longitudinal strain, left ventricular ejection fraction, left ventricular outflow tract velocity-time integral, cardiac output, and diastolic function indices will be assessed before and after atrioventricular delay optimization.
The study will investigate whether optimization of atrioventricular timing provides additional mechanical and hemodynamic benefits beyond physiological ventricular activation achieved by conduction system pacing alone.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Conduction system pacing (CSP), including His bundle pacing and left bundle branch area pacing, has emerged as a physiological pacing strategy capable of preserving ventricular electrical activation and reducing pacing-induced dyssynchrony. Compared with conventional right ventricular pacing, CSP has been associated with improved electrical synchrony, ventricular function, and clinical outcomes.
Despite restoration of physiological ventricular activation, optimal atrioventricular (AV) coupling remains essential for maximizing ventricular filling, stroke volume, and overall cardiac performance. Inadequate AV timing may impair diastolic filling, reduce atrial contribution to ventricular preload, and limit the hemodynamic benefits achieved by physiological pacing. While AV delay optimization has been extensively investigated in cardiac resynchronization therapy, data regarding its role in patients undergoing CSP remain limited.
The present study evaluates the impact of individualized echocardiography-guided AV delay optimization on ventricular mechanical performance and hemodynamic parameters in patients with CSP implanted for atrioventricular block. Comprehensive transthoracic echocardiographic assessment will be performed before and after AV delay optimization. Measurements include left ventricular ejection fraction, global longitudinal strain, left ventricular outflow tract velocity-time integral, cardiac output, chamber dimensions, pulmonary artery systolic pressure, and diastolic function parameters.
The primary objective is to determine the effect of AV delay optimization on global longitudinal strain. Secondary objectives include assessment of changes in left ventricular systolic function, hemodynamic performance, and diastolic parameters. The study aims to provide additional evidence regarding the importance of individualized AV programming in patients undergoing conduction system pacing.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Yıldırım
-
Bursa, Yıldırım, Turkey (Türkiye)
- University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Age between 18 and 80 years Permanent conduction system pacing implantation for atrioventricular block At least 1 month elapsed since device implantation Sinus rhythm at the time of enrollment Left ventricular ejection fraction >40% Adequate echocardiographic image quality for comprehensive assessment Ability and willingness to provide informed consent
Exclusion Criteria:
Permanent or persistent atrial fibrillation Significant valvular heart disease Active malignancy Severe systemic illness with limited life expectancy Sinus node dysfunction requiring alternative pacing strategies Inadequate echocardiographic image quality Inability to comply with study procedures Refusal to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Echocardiography-Guided AV Delay Optimization
Participants with conduction system pacing undergo individualized echocardiography-guided atrioventricular delay optimization.
Echocardiographic and hemodynamic parameters are assessed before and after optimization.
|
Atrioventricular delay settings are individually optimized using echocardiographic assessment of transmitral inflow and ventricular filling patterns.
Device programming is adjusted to achieve optimal atrioventricular coupling and ventricular performance.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global Longitudinal Strain (GLS)
Time Frame: Immediately before and immediately after atrioventricular delay optimization.
|
Assessment of left ventricular global longitudinal strain using two-dimensional speckle tracking echocardiography before and after atrioventricular delay optimization.
|
Immediately before and immediately after atrioventricular delay optimization.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Left Ventricular Outflow Tract Velocity-Time Integral (LVOT VTI)
Time Frame: Immediately before and immediately after atrioventricular delay optimization.
|
Assessment of forward stroke volume using pulsed-wave Doppler measurements at the left ventricular outflow tract.
|
Immediately before and immediately after atrioventricular delay optimization.
|
|
Left Ventricular Ejection Fraction (LVEF)
Time Frame: Immediately before and immediately after atrioventricular delay optimization.
|
Assessment of left ventricular systolic function using the biplane Simpson method.
|
Immediately before and immediately after atrioventricular delay optimization.
|
Collaborators and Investigators
Investigators
- Study Chair: Ahmet Tütüncü, Bursa Yuksek Ihtisas Training and Research Hospital
Publications and helpful links
General Publications
- Glikson et al. ESC Clinical Consensus Statement on Conduction System Pacing Glikson M, Vijayaraman P, Ellenbogen KA, et al. European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing. Europace. 2025;27(4):euaf050. Coluccia et al. Optimization of the Atrioventricular Delay in Conduction System Pacing Coluccia G, Padeletti L, Della Bella P, et al. Optimization of the atrioventricular delay in conduction system pacing. J Cardiovasc Electrophysiol. 2023;34(6):1441-1451. Pujol-López et al. LEVEL-AT Trial Secondary Findings Pujol-López M, et al. Longitudinal comparison of dyssynchrony correction and strain improvement by conduction system pacing: LEVEL-AT trial secondary findings. Eur Heart J Cardiovasc Imaging. 2024;25(10):1394-1404. Hua et al. Comparison of Left Bundle Branch and His Bundle Pacing Hua W, Fan X, Niu H, et al. Comparison of left bundle branch and His bundle pacing in bradycardia patients. JACC Clin Electrophysiol. 2020;6(10):1291-1299. Sweeney et al. Adverse Effect of Ventricular Pacing Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration. Circulation. 2003;107(23):2932-2937.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BYIEAH-CSP-BMU-2025
- 2024-TBEK 2025/07-12 (Other Identifier: SBÜ Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrioventricular Block
-
University Hospital of FerraraRecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Left Bundle-Branch Block | Bundle-Branch Block | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Atrioventricular Block | Heart Failure, Systolic | Ventricular Arrythmia | Heart Failure,Congestive | Bradyarrhythmia | Heart Arrhythmia | Reduced... and other conditionsItaly
-
University of Sao PauloUnknownCongenital Complete Atrioventricular Heart Block | High Grade Atrioventricular Block | Postoperative Complete Heart BlockBrazil
-
Ningbo No.2 HospitalNot yet recruiting
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai Hospital... and other collaboratorsUnknownBradycardia | Sick Sinus Syndrome | High Degree Second Degree Atrioventricular Block | Complete Atrioventricular BlockChina
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai Hospital... and other collaboratorsUnknownBradycardia | Sick Sinus Syndrome | Complete Atrioventricular Block | High Degree Second Degree Atrioventricular Block (Disorder)China
-
Habib KhanAcademic Medical Organization of Southwestern OntarioActive, not recruitingBundle-Branch Block | Conduction Block, AtrioventricularCanada
-
West China HospitalRecruitingAVB - Atrioventricular BlockChina
-
Medtronic Cardiac Rhythm and Heart FailureCompletedAtrioventricular Conduction BlockDenmark, United States, Belgium, Italy, Malaysia, Spain, France, Austria, Czechia
-
Medtronic Cardiac Rhythm and Heart FailureCompletedAtrioventricular Conduction BlockUnited States, Belgium, Hong Kong, Malaysia, Spain, Austria, Denmark, France
-
Gianluca BottoUnknownFirst Degree Atrioventricular BlockItaly
Clinical Trials on Echocardiography-Guided Atrioventricular Delay Optimization
-
Military Institute of Medicine, PolandUnknown
-
Istanbul UniversityCompletedPacemaker DDD | Aortic Aneurysm | Aortic DiseasesTurkey
-
Hospital Clinic of BarcelonaFundacio Clinic BarcelonaCompletedHeart Failure | Cardiac Resynchronization TherapySpain
-
University Hospital DubravaCompletedHypotension During SurgeryCroatia
-
Universitaire Ziekenhuizen KU LeuvenJessa Ziekenhuis HasseltRecruiting
-
Sheba Medical CenterCompletedCongestive Heart FailureIsrael
-
University Hospital HeidelbergRecruiting
-
Vilnius University Hospital Santaros KlinikosVilnius UniversityCompletedMyocardial Infarction | Myocardial Ischemia | Coronary Artery Disease
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruiting